PROC Promoter Single Nucleotide Polymorphisms Associated With Low Protein C Activity But Not Increased Risk of Thromboembolism in Pediatric Population

Udomkittivorakul, Natsumon; Sasanakul, Werasak; Eu-ahsunthornwattana, Jakris; Chuansumrit, Ampaiwan; Komwilaisak, Patcharee; Songdej, Duantida; Sirachainan, Nongnuch

doi:10.1177/1076029620935206

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Rare genetic polymorphisms in the human PC can cause PC deficiency states due to reduced secretion or synthesis of PC (Type I) or changed PC structure (Type II) [11]. On the other hand, common genetic polymorphisms have also been suggested to be associated with relative PC deficiency and with altered outcomes in disorders such as pulmonary embolism, venous thrombosis, cardiovascular disease, stroke, sepsis, and systemic meningococcemia [12][13][14]. Moreover, previous studies have demonstrated that the genetic variants of human PC contribute not only to diseases and disorders but also to the inter-individual variability in dose requirements for anticoagulant drugs such as warfarin.…”

Section: Introductionmentioning

confidence: 99%

Computational analysis of the functional and structural impact of the most deleterious missense mutations in the human Protein C

Farajzadeh-Dehkordi,

Mafakher,

Harifi

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

Protein C (PC) is a vitamin K-dependent factor that plays a crucial role in controlling anticoagulant processes and acts as a cytoprotective agent to promote cell survival. Several mutations in human PC are associated with decreased protein production or altered protein structure, resulting in PC deficiency. In this study, we conducted a comprehensive analysis of nonsynonymous single nucleotide polymorphisms in human PC to prioritize and confirm the most high-risk mutations predicted to cause disease. Of the 340 missense mutations obtained from the NCBI database, only 26 were classified as high-risk mutations using various bioinformatic tools. Among these, we identified that 12 mutations reduced the stability of protein, and thereby had the greatest potential to disturb protein structure and function. Molecular dynamics simulations revealed moderate alterations in the structural stability, flexibility, and secondary structural organization of the serine protease domain of human PC for five missense mutations (L305R, W342C, G403R, V420E, and W444C) when compared to the native structure that could maybe influence its interaction with other molecules. Protein-protein interaction analyses demonstrated that the occurrence of these five mutations can affect the regular interaction between PC and activated factor V. Therefore, our findings assume that these mutants can be used in the identification and development of therapeutics for diseases associated with PC dysfunction, although assessment the effect of these mutations need to be proofed in in-vitro.

show abstract